221 related articles for article (PubMed ID: 31992595)
21. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
22. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
23. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation.
Lee SY; Long F
J Clin Invest; 2018 Dec; 128(12):5573-5586. PubMed ID: 30284985
[TBL] [Abstract][Full Text] [Related]
24. Hairy and Enhancer of Split-Related With YRPW Motif-Like (HeyL) Is Dispensable for Bone Remodeling in Mice.
Canalis E; Zanotti S
J Cell Biochem; 2017 Jul; 118(7):1819-1826. PubMed ID: 28019674
[TBL] [Abstract][Full Text] [Related]
25. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.
Zhao W; Petit E; Gafni RI; Collins MT; Robey PG; Seton M; Miller KK; Mannstadt M
Osteoporos Int; 2013 Aug; 24(8):2275-81. PubMed ID: 23389697
[TBL] [Abstract][Full Text] [Related]
26. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis.
Isidor B; Lindenbaum P; Pichon O; Bézieau S; Dina C; Jacquemont S; Martin-Coignard D; Thauvin-Robinet C; Le Merrer M; Mandel JL; David A; Faivre L; Cormier-Daire V; Redon R; Le Caignec C
Nat Genet; 2011 Mar; 43(4):306-8. PubMed ID: 21378989
[TBL] [Abstract][Full Text] [Related]
27. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
Zanotti S; Canalis E
J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
[TBL] [Abstract][Full Text] [Related]
28. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
Fujiwara T; Zhou J; Ye S; Zhao H
Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
[TBL] [Abstract][Full Text] [Related]
29. The Hajdu Cheney Mutation Is a Determinant of B-Cell Allocation of the Splenic Marginal Zone.
Yu J; Zanotti S; Walia B; Jellison E; Sanjay A; Canalis E
Am J Pathol; 2018 Jan; 188(1):149-159. PubMed ID: 29037852
[TBL] [Abstract][Full Text] [Related]
30. Phenotype variability in Hajdu-Cheney syndrome.
Regev M; Pode-Shakked B; Jacobson JM; Raas-Rothschild A; Goldstein DB; Anikster Y
Eur J Med Genet; 2019 Jan; 62(1):35-38. PubMed ID: 29698804
[TBL] [Abstract][Full Text] [Related]
31. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.
Sakka S; Gafni RI; Davies JH; Clarke B; Tebben P; Samuels M; Saraff V; Klaushofer K; Fratzl-Zelman N; Roschger P; Rauch F; Högler W
J Clin Endocrinol Metab; 2017 Nov; 102(11):4163-4172. PubMed ID: 28938420
[TBL] [Abstract][Full Text] [Related]
32. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.
Majewski J; Schwartzentruber JA; Caqueret A; Patry L; Marcadier J; Fryns JP; Boycott KM; Ste-Marie LG; McKiernan FE; Marik I; Van Esch H; ; Michaud JL; Samuels ME
Hum Mutat; 2011 Oct; 32(10):1114-7. PubMed ID: 21681853
[TBL] [Abstract][Full Text] [Related]
33. Antisense oligonucleotides targeting a NOTCH3 mutation in male mice ameliorate the cortical osteopenia of lateral meningocele syndrome.
Canalis E; Mocarska M; Schilling L; Jafar-Nejad P; Carrer M
Bone; 2023 Dec; 177():116898. PubMed ID: 37704069
[TBL] [Abstract][Full Text] [Related]
34. A novel NOTCH2 mutation identified in a Korean family with Hajdu-Cheney syndrome showing phenotypic diversity.
Han MS; Ko JM; Cho TJ; Park WY; Cheong HI
Ann Clin Lab Sci; 2015; 45(1):110-4. PubMed ID: 25696021
[TBL] [Abstract][Full Text] [Related]
35. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
Isidor B; Le Merrer M; Exner GU; Pichon O; Thierry G; Guiochon-Mantel A; David A; Cormier-Daire V; Le Caignec C
Hum Mutat; 2011 Nov; 32(11):1239-42. PubMed ID: 21793104
[TBL] [Abstract][Full Text] [Related]
36. Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review.
Zeng C; Lin Y; Lu Z; Chen Z; Jiang X; Mao X; Liu Z; Lu X; Zhang K; Yu Q; Wang X; Huang Y; Liu L
BMC Musculoskelet Disord; 2020 Mar; 21(1):154. PubMed ID: 32143606
[TBL] [Abstract][Full Text] [Related]
37. Hajdu-Cheney Syndrome: A Systematic Review of the Literature.
Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Rodríguez-Blanque R; Bermejo-Fernández A; Sánchez-García JC
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854429
[TBL] [Abstract][Full Text] [Related]
38. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome.
Stathopoulos IP; Trovas G; Lampropoulou-Adamidou K; Koromila T; Kollia P; Papaioannou NA; Lyritis G
Bone; 2013 Jan; 52(1):366-71. PubMed ID: 23117206
[TBL] [Abstract][Full Text] [Related]
39. A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
Efstathiadou ZA; Kostoulas C; Polyzos SA; Adamidou F; Georgiou I; Kita M
Endocrine; 2021 Jan; 71(1):208-215. PubMed ID: 32772338
[TBL] [Abstract][Full Text] [Related]
40. A mutation in NOTCH2 gene in a Chinese patient with Hajdu-Cheney syndrome.
Gu JM; Hu YQ; Zhang H; Wang C; Hu WW; Yue H; Liu YJ; Zhang ZL
Joint Bone Spine; 2013 Oct; 80(5):548-9. PubMed ID: 23566664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
